We are live on
!
Find out more
CCM
Carderock Capital Management Portfolio holdings
AUM
$456M
1-Year Est. Return
31.89%
This Fund
S&P 500
This Quarter
Est. Return
+0.99%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$201M
AUM Growth
+$781K
(+0.39%)
Cap. Flow
+$614K
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
28.32%
Holding
83
New
5
Increased
29
Reduced
36
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.11M |
| 2 |
Chevron
CVX
|
+$1.91M |
| 3 |
Home Depot
HD
|
+$1.45M |
| 4 |
Equifax
EFX
|
+$1.34M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$2.23M |
| 2 |
CVS Health
CVS
|
+$2.14M |
| 3 |
CERN
Cerner Corp
CERN
|
+$1.89M |
| 4 |
PPG Industries
PPG
|
+$1.28M |
| 5 |
Wells Fargo
WFC
|
+$1.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.39% |
| 2 | Healthcare | 19.5% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 8.51% |
| 5 | Consumer Staples | 7.32% |
Similar funds
HFF
FIM
EGP
AWM
EIA
BRF
TCMP
FC
Carderock Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Carderock Capital Management held 83 positions worth $201M, up 0.39% from $200M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Carderock Capital Management's Q4 2016 filing shows 5 new, 29 increased, 36 reduced and 6 closed positions. Its largest new stake was Meta Platforms (Facebook): 10,631 shares worth $1.22M. The largest sale was Novo Nordisk, an estimated $2.23M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
- Carderock Capital Management's largest Q4 2016 buy was Meta Platforms (Facebook): 10,631 shares worth $1.22M.
- Carderock Capital Management added most to SLB Ltd in Q4 2016, an estimated $2.11M increase.
- Carderock Capital Management's biggest Q4 2016 reduction was Novo Nordisk, cutting an estimated $2.23M.
- Carderock Capital Management fully exited CVS Health in Q4 2016, selling an estimated $2.14M.
- Carderock Capital Management's ten largest holdings make up 28% of its $201M portfolio in Q4 2016.
- Carderock Capital Management opened 5 new positions and closed 6 in Q4 2016.
- Carderock Capital Management's portfolio value rose 0.39% quarter-over-quarter to $201M.
Based on Carderock Capital Management's 13F filing for Q4 2016, filed 8 Feb 2017.